The FDA approved Eli Lilly’s new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market

1 week ago 9

The drugmaker’s pill volition instrumentality connected a rival from Novo Nordisk successful the booming multibillion-dollar obesity cause market.